CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C03204 | BRD-K02492147 | BRD-K02492147 | -- | -- | -- | Details |
| C03205 | BRD-K02501528 | S-18986 | -- | -- | -- | Details |
| C03206 | BRD-K02502363 | BRD-K02502363 | -- | -- | -- | Details |
| C03207 | BRD-K02511275 | BRD-K02511275 | -- | -- | -- | Details |
| C03208 | BRD-K02515288 | BRD-K02515288 | -- | -- | -- | Details |
| C03209 | BRD-K02516751 | BRD-K02516751 | -- | -- | -- | Details |
| C03210 | BRD-K02517738 | BRD-K02517738 | -- | -- | -- | Details |
| C03211 | BRD-K02519835 | BRD-K02519835 | -- | -- | -- | Details |
| C03212 | BRD-K02522894 | BRD-K02522894 | -- | -- | -- | Details |
| C03213 | BRD-K02526659 | BRD-K02526659 | -- | -- | -- | Details |
| C03214 | BRD-K02526760 | QS-11 | ARFGAP1 | ARFGAP inhibitor | -- | Details |
| C03215 | BRD-K02529187 | BRD-K02529187 | -- | -- | -- | Details |
| C03216 | BRD-K02530287 | BRD-K02530287 | -- | -- | -- | Details |
| C03217 | BRD-K02535446 | BRD-K02535446 | -- | -- | -- | Details |
| C03218 | BRD-K02537686 | BRD-K02537686 | -- | -- | -- | Details |
| C03219 | BRD-K02541615 | BRD-K02541615 | -- | -- | -- | Details |
| C03220 | BRD-K02544589 | BRD-K02544589 | -- | -- | -- | Details |
| C03221 | BRD-K02544880 | BRD-K02544880 | -- | -- | -- | Details |
| C03222 | BRD-K02545368 | BRD-K02545368 | -- | -- | -- | Details |
| C03223 | BRD-K02548021 | BRD-K02548021 | -- | -- | -- | Details |
| C03224 | BRD-K02548315 | BRD-K02548315 | -- | -- | -- | Details |
| C03225 | BRD-K02549628 | BRD-K02549628 | -- | -- | -- | Details |
| C03226 | BRD-K02558072 | BRD-K02558072 | -- | -- | -- | Details |
| C03227 | BRD-K02559684 | BRD-K02559684 | -- | -- | -- | Details |
| C03228 | BRD-K02560333 | BRD-K02560333 | -- | -- | -- | Details |
| C03229 | BRD-K02562327 | BRD-K02562327 | -- | -- | -- | Details |
| C03230 | BRD-K02563170 | BRD-K02563170 | -- | -- | -- | Details |
| C03231 | BRD-K02565327 | BRD-K02565327 | -- | -- | -- | Details |
| C03232 | BRD-K02571615 | benfotiamine | AGER | Antioxidant | -- | Details |
| C03233 | BRD-K02575886 | BRD-K02575886 | -- | -- | -- | Details |
| C03234 | BRD-K02576169 | BRD-K02576169 | -- | -- | -- | Details |
| C03235 | BRD-K02577117 | BRD-K02577117 | -- | -- | -- | Details |
| C03236 | BRD-K02581333 | BRD-K02581333 | -- | -- | protein-tyrosine-phosphatase-inhibitor-IV | Details |
| C03237 | BRD-K02581961 | BRD-K02581961 | -- | -- | -- | Details |
| C03238 | BRD-K02589376 | SD-6-035-A9 | -- | -- | -- | Details |
| C03239 | BRD-K02590140 | O-2050 | CNR1 | Cannabinoid receptor antagonist | -- | Details |
| C03240 | BRD-K02590376 | SA-103021 | -- | -- | -- | Details |
| C03241 | BRD-K02593152 | BRD-K02593152 | -- | -- | -- | Details |
| C03242 | BRD-K02598395 | BRD-K02598395 | -- | -- | -- | Details |
| C03243 | BRD-K02602127 | BRD-K02602127 | -- | -- | -- | Details |
| C03244 | BRD-K02602944 | BRD-K02602944 | -- | -- | -- | Details |
| C03245 | BRD-K02603382 | 1-methylisoquinoline | -- | -- | 1-METHYLISOQUINOLINE | Details |
| C03246 | BRD-K02607075 | tubocurarine | CHRNA2; HTR3A | Acetylcholine receptor antagonist | -- | Details |
| C03247 | BRD-K02610196 | BRD-K02610196 | -- | -- | -- | Details |
| C03248 | BRD-K02612980 | BRD-K02612980 | -- | -- | -- | Details |
| C03249 | BRD-K02614439 | BRD-K02614439 | -- | -- | -- | Details |
| C03250 | BRD-K02624294 | BRD-K02624294 | -- | -- | -- | Details |
| C03251 | BRD-K02624724 | BRD-K02624724 | -- | -- | -- | Details |
| C03252 | BRD-K02625776 | BRD-K02625776 | -- | -- | -- | Details |
| C03253 | BRD-K02630367 | BRD-K02630367 | -- | -- | -- | Details |
| C03254 | BRD-K02634083 | BRD-K02634083 | -- | -- | -- | Details |
| C03255 | BRD-K02635441 | BRD-K02635441 | -- | -- | -- | Details |
| C03256 | BRD-K02636305 | BRD-K02636305 | -- | -- | -- | Details |
| C03257 | BRD-K02637541 | celecoxib | PTGS2 | Cyclooxygenase inhibitor | -- | Details |
| C03258 | BRD-K02637547 | BRD-K02637547 | -- | -- | -- | Details |
| C03259 | BRD-K02637850 | BRD-K02637850 | -- | -- | -- | Details |
| C03260 | BRD-K02638906 | BRD-K02638906 | -- | -- | -- | Details |
| C03261 | BRD-K02641134 | BRD-K02641134 | -- | -- | -- | Details |
| C03262 | BRD-K02646507 | KU-C104250 | -- | -- | -- | Details |
| C03263 | BRD-K02653582 | BRD-K02653582 | -- | -- | -- | Details |
| C03264 | BRD-K02653676 | BRD-K02653676 | -- | -- | -- | Details |
| C03265 | BRD-K02654447 | BRD-K02654447 | -- | -- | -- | Details |
| C03266 | BRD-K02655584 | BRD-K02655584 | -- | -- | -- | Details |
| C03267 | BRD-K02665621 | BRD-K02665621 | -- | -- | -- | Details |
| C03268 | BRD-K02671211 | BRD-K02671211 | -- | -- | -- | Details |
| C03269 | BRD-K02675272 | BRD-K02675272 | -- | -- | -- | Details |
| C03270 | BRD-K02675466 | BRD-K02675466 | -- | -- | -- | Details |
| C03271 | BRD-K02677403 | SA-424380 | -- | -- | -- | Details |
| C03272 | BRD-K02680176 | clofilium | -- | -- | -- | Details |
| C03273 | BRD-K02681754 | BRD-K02681754 | -- | -- | -- | Details |
| C03274 | BRD-K02688026 | BRD-K02688026 | -- | -- | -- | Details |
| C03275 | BRD-K02689622 | BRD-K02689622 | -- | -- | -- | Details |
| C03276 | BRD-K02691653 | BRD-K02691653 | -- | -- | -- | Details |
| C03277 | BRD-K02694971 | BRD-K02694971 | -- | -- | -- | Details |
| C03278 | BRD-K02701279 | BRD-K02701279 | -- | -- | -- | Details |
| C03279 | BRD-K02707544 | BRD-K02707544 | -- | -- | -- | Details |
| C03280 | BRD-K02708799 | GSK-1059615 | -- | -- | -- | Details |
| C03281 | BRD-K02715134 | BRD-K02715134 | -- | -- | -- | Details |
| C03282 | BRD-K02715688 | hydrastine | -- | -- | hydrastine-(1r,-9s) | Details |
| C03283 | BRD-K02717912 | BRD-K02717912 | -- | -- | -- | Details |
| C03284 | BRD-K02719847 | BRD-K02719847 | -- | -- | -- | Details |
| C03285 | BRD-K02724364 | BRD-K02724364 | -- | -- | -- | Details |
| C03286 | BRD-K02732091 | BRD-K02732091 | -- | -- | -- | Details |
| C03287 | BRD-K02733959 | cefuroxime | -- | -- | -- | Details |
| C03288 | BRD-K02734624 | BRD-K02734624 | -- | -- | -- | Details |
| C03289 | BRD-K02735834 | BRD-K02735834 | -- | -- | -- | Details |
| C03290 | BRD-K02747732 | BRD-K02747732 | -- | -- | -- | Details |
| C03291 | BRD-K02749944 | BRD-K02749944 | -- | -- | -- | Details |
| C03292 | BRD-K02750843 | BRD-K02750843 | -- | -- | -- | Details |
| C03293 | BRD-K02756145 | BRD-K02756145 | -- | -- | -- | Details |
| C03294 | BRD-K02759046 | BRD-K02759046 | -- | -- | -- | Details |
| C03295 | BRD-K02764265 | BRD-K02764265 | -- | -- | -- | Details |
| C03296 | BRD-K02764365 | methiazole | -- | -- | -- | Details |
| C03297 | BRD-K02772785 | BRD-K02772785 | -- | -- | -- | Details |
| C03298 | BRD-K02778241 | BRD-K02778241 | -- | -- | -- | Details |
| C03299 | BRD-K02778838 | BRD-K02778838 | -- | -- | -- | Details |
| C03300 | BRD-K02781189 | BRD-K02781189 | -- | -- | -- | Details |
| C03301 | BRD-K02781692 | BRD-K02781692 | -- | -- | -- | Details |
| C03302 | BRD-K02783902 | BRD-K02783902 | -- | -- | -- | Details |
| C03303 | BRD-K02785641 | BRD-K02785641 | -- | -- | -- | Details |